CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the quarterly Report of Amarantus Biosciences, Inc. (the “Company”) on Form 10-Q for the quarter ended April 30, 2011 filed with the Securities and Exchange Commission (the “Report”), We, Martin D. Cleary, Chief Executive Officer of the Company, and Marc E. Faerber, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.             The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

2.             The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

 

By: /s/Martin D. Cleary
Name: Martin D. Cleary
Title: Principal Executive Officer and Director
Date: June 20, 2011
   
By: /s/Marc E. Faerber
Name:  Marc E. Faerber
Title:  Chief Financial Officer
Date:  June 20, 2011

 

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.